Healthcare -
Biotechnology - NASDAQ - US
$ 1.32
6.3 %
$ 841 M
Market Cap
-5.0
P/E
GERN - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities GERN - Geron Corporation
-106 M
LAST VALUE
-64.56%
2 YEAR CAGR
-37.24%
5 YEAR CAGR
-3.13%
10 YEAR CAGR